-
-
Call more information
660-596-2224 -
Authors: Adam Striker, MD, FASA et al ASA Monitor November 2022, Vol. 86, 28–29. Building Long-Term Communication Success is the final subject in a four-part article series that provides more information about ASA’s Enhancing Patient Communications Program. ASA has received positive feedback on the guidance in our Enhancing Patient Communications Program toolkit, specifically its importance. The […]
Read MoreAUTHORS: De Biasio, Justin C. MD et al Anesthesia & Analgesia: June 2020 – Volume 130 – Issue 6 – p 1462-1473 Abstract Traditional approaches to clinical risk assessment utilize age as a marker of increased vulnerability to stress. Relatively recent advancements in the study of aging have led to the concept of the frailty syndrome, […]
Read MoreASA Monitor November 2022, Vol. 86, 17. According to recent recommendations from an ASA expert panel, which of the following examinations is MOST likely a primary application of diagnostic point-of-care ultrasound (POCUS) for anesthesiologists? □ (A) Airway □ (B) Musculoskeletal □ (C) Focused assessment with sonography in trauma (FAST) The use of POCUS has been gaining momentum since the […]
Read MoreASA Monitor November 2022, Vol. 86, 13. A patient with opioid use disorder is receiving buprenorphine. Treatment adherence is monitored using urine drug testing. Detection of which of the following in this patient’s urine sample would MOST likely indicate that it had been adulterated? □ (A) Buprenorphine □ (B) Low levels of norbuprenorphine □ (C) Low levels of thebaine […]
Read MoreAUTHORS: Kussman, Barry D. MBBCh, FFA(SA) et al Anesthesia & Analgesia: August 2021 – Volume 133 – Issue 2 – p 379-392 Abstract Transcranial Doppler (TCD) ultrasonography is the only noninvasive bedside technology for the detection and monitoring of cerebral embolism. TCD may identify patients at risk of acute and chronic neurologic injury from gaseous or […]
Read MoreAuthors: Michelle L. Humeidan, MD, PhD; Daniel J. Cole, MD, FASA ASA Monitor November 2022, Vol. 86, 1–6. Life is most delightful when it is on the downward slope, but has not yet reached the abrupt decline. – Seneca We have all encountered geriatric patients amid or on the precipice of an “abrupt decline” in health. Our aim […]
Read MoreASA Monitor November 2022, Vol. 86, 14–15. Trends FDA authorizes emergency use of JYNNEOS to increase monkeypox vaccine supply The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) allowing health care providers to use the JYNNEOS vaccine by intradermal injection for individuals 18 years of age and older who are at high […]
Read MoreAuthors: Zachary Deutch, MD, FASA; David A. Zvara, MD, FASA ASA Monitor November 2022, Vol. 86, 33–34. Dr. Zvara discussing a case with Jennifer Tripi, CA-2. “UNC is home to over 60 core program residents and fellows in pain medicine, regional anesthesia, pediatric anesthesia, and research,” Dr. Zvara said. “Our residents are truly the heart of our […]
Read MoreAuthors: Katherine Grichnik, MD, MS, FASE et al ASA Monitor November 2022, Vol. 86, 24–25. The primary challenge facing anesthesiology practices nationwide is the shortage of anesthesia providers. While efforts to address provider supply are necessary, maximizing the capacity of our current teams to provide care is essential. This requires systems and processes that optimize the […]
Read MoreAuthors: Basem B. Abdelmalak, MD, FASA, SAMBA-F et al ASA Monitor November 2022, Vol. 86, 26–27. Driven by advances in minimally invasive diagnostic and therapeutic procedures, the demand for anesthesia and procedural sedation outside the OR has expanded more rapidly than ever. This has placed tremendous strain on anesthesiology departments, both to fulfill anesthesia service needs […]
Read More